tanshinone ii a has been researched along with chloranil in 2 studies
Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) | Studies (chloranil) | Trials (chloranil) | Recent Studies (post-2010) (chloranil) |
---|---|---|---|---|---|
61 | 0 | 41 | 193 | 0 | 62 |
Protein | Taxonomy | tanshinone ii a (IC50) | chloranil (IC50) |
---|---|---|---|
Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 4.1 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 2.06 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
2 other study(ies) available for tanshinone ii a and chloranil
Article | Year |
---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |